These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2817909

  • 21. [Rapid disappearance of M-protein in multiple myeloma complicated by pneumonia during treatment with HLBI].
    Ashihara E, Oku N, Nishio A, Tuji K, Nakamura M.
    Rinsho Ketsueki; 1992 Dec; 33(12):1818-23. PubMed ID: 1479692
    [Abstract] [Full Text] [Related]

  • 22. [The therapy of renal cell carcinoma with human lymphoblastoid interferon].
    Masuda F, Suzuki M, Ikemoto I, Yamazaki H, Machida T.
    Hinyokika Kiyo; 1984 May; 30(5):615-9. PubMed ID: 6206703
    [Abstract] [Full Text] [Related]

  • 23. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
    Suzuki A, Iwase O, Ohkubo T, Nakano M, Toyama K.
    Rinsho Ketsueki; 1991 Jan; 32(1):47-51. PubMed ID: 1902271
    [Abstract] [Full Text] [Related]

  • 24. [Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].
    Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J.
    Vnitr Lek; 2001 Sep; 47 Suppl 1():40-7. PubMed ID: 11693062
    [Abstract] [Full Text] [Related]

  • 25. [Clinical effects of human fibroblast interferon on malignant tumors].
    Ezaki K, Okabe K, Inagaki J, Horikoshi N, Inoue K, Aiba K, Domyo M, Nagata T, Ogawa M.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):31-7. PubMed ID: 7184362
    [Abstract] [Full Text] [Related]

  • 26. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
    Takemori N, Kondo K, Kawamura T, Imai K, Sakurai H, Sato T.
    Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
    [Abstract] [Full Text] [Related]

  • 27. Hypoparathyroidism during alpha-INF therapy in a patient with multiple myeloma.
    Ueki K, Tsuchida A, Murakami H, Yano S, Kobayashi N, Omine M, Naruse T.
    J Med; 1989 Jan; 20(5-6):391-7. PubMed ID: 2628520
    [Abstract] [Full Text] [Related]

  • 28. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K, Mura M, Deguchi N, Baba S, Jitsukawa S, Nakazono M, Tazaki H.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
    [Abstract] [Full Text] [Related]

  • 29. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Jul; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 30. [Effects of interferon on various malignancies].
    Taguchi T.
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [Abstract] [Full Text] [Related]

  • 31. Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.
    Pönisch W, Rozanski M, Goldschmidt H, Hoffmann FA, Boldt T, Schwarzer A, Ritter U, Rohrberg R, Schwalbe E, Uhlig J, Zehrfeld T, Schirmer V, Haas A, Kreibich U, Niederwieser D, East German Study Group of Haematology and Oncology (OSHO).
    Br J Haematol; 2008 Oct; 143(2):191-200. PubMed ID: 18752593
    [Abstract] [Full Text] [Related]

  • 32. [VCAP chemotherapy combined with interferon-alpha (HLBI) for elderly multiple myeloma].
    Umeda M, Katoh M, Niitsu N, Takata M, Katoh M, Shikoshi K.
    Nihon Ronen Igakkai Zasshi; 1994 Dec; 31(12):969-74. PubMed ID: 7699945
    [Abstract] [Full Text] [Related]

  • 33. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
    Kanno H, Kitami K, Senga Y, Takahashi T, Nagashima Y.
    Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
    [Abstract] [Full Text] [Related]

  • 34. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D, Rajkumar SV, Nowakowski GS, Gertz MA, Dispenzieri A, Lacy MQ, Hayman S, Fonseca R, Lust JA, Kyle RA, Greipp PR, Witzig TE.
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [Abstract] [Full Text] [Related]

  • 35. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR, Fefer A, Thompson J, Case DC, Kempf R, Sacher R, Neefe J, Bickers J, Scarffe JH, Spiegel R.
    Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group.
    Palva IP, Ala-Harja K, Almqvist A, Elonen E, Hallman H, Hänninen A, Ilvonen M, Isomaa B, Jouppila J, Järvenpää E.
    Eur J Haematol; 1993 Aug; 51(2):98-101. PubMed ID: 8370425
    [Abstract] [Full Text] [Related]

  • 38. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Ahmad I, Islam T, Chanan-Khan A, Hahn T, Wentling D, Becker JL, McCarthy PL, Alam AR.
    Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306
    [Abstract] [Full Text] [Related]

  • 39. [Clinical investigation of interferons in the preleukemic state (CML and MDS)].
    Koyama S.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1191-7. PubMed ID: 3132893
    [Abstract] [Full Text] [Related]

  • 40. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM, Leong T, Lenhard RE, Greipp PR, Kay NE, Van Ness B, Keimowitz RM, Kyle RA.
    Cancer; 1999 Sep 15; 86(6):957-68. PubMed ID: 10491521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.